Protein detail
WASP
Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)
Entry name WASP | UniProt ID | EVMP confidence score 0.60 |
Supporting publications (n) 15 | Transmembrane count | Protein classification Cancer-related genesDisease related genesHuman disease related genesPredicted intracellular proteins |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information11
Protein Names
Actin nucleation-promoting factor WAS (Wiskott-Aldrich syndrome protein) (WASp)
Protein Class (4)
Cancer-related genesDisease related genesHuman disease related genesPredicted intracellular proteins
Protein Function (5)
- Human disease related genes:Cardiovascular diseases:Hematologic diseases
- Predicted intracellular proteins
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Cancer-related genes
- Disease related genes
Ensembl
Entrez Gene Symbol
Gene Synonym (4)
IMD2THCWASPWASPA
Gene Description
WASP actin nucleation promoting factor
Chromosome
X
Position
48676596-48691431
Supporting publications (n)
15
EVMP confidence score
0.60
Fluorescence & Localization3
Tissue Specificchoroid plexusCell SpecificEndometrial ciliated cellsSingle-Nuclei Brain Specificchoroid plexus epithelial cell
Function & Pathway7
Protein Function (5)
- Human disease related genes:Cardiovascular diseases:Hematologic diseases
- Predicted intracellular proteins
- Human disease related genes:Immune system diseases:Primary immunodeficiency
- Cancer-related genes
- Disease related genes
Cellular Component (10)
Molecular Function (8)
Biological Process (3)
KEGG (6)
Reactome (15)
- R-hsa-1280218 adaptive immune system
- R-hsa-9013148 cdc42 gtpase cycle
- R-hsa-2029480 fcgamma receptor fcgr dependent phagocytosis
- R-hsa-202433 generation of second messenger molecules
- R-hsa-5663205 infectious disease
- R-hsa-168249 innate immune system
- R-hsa-9658195 leishmania infection
- R-hsa-9664407 parasite infection
- R-hsa-9013149 rac1 gtpase cycle
- R-hsa-9013409 rhoj gtpase cycle
Page 1 of 2
Mediation Categories (4)
Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation
Relations & Evidence85
Enzyme-Mediated Modification (21)
21 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| WAS | ALK | Q9UM73 | Y | 291 | phosphorylation | RLIMS-P_ProtMapperProtMapper | ProtMapper:27694894 |
Page 3 of 3Previous
Ligand-Receptor Signaling (5)
5 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| intracellular | intracellular | LOCATE | No | No | No | No | No |
| intracellular | intracellular | ComPPI | No | No | No | No | No |
| intracellular | intracellular | GO_Intercell | No | No | No | No | No |
| intracellular | intracellular | UniProt_location | No | No | No | No | No |
| intracellular | intracellular | OmniPath | No | No | No | No | No |
Regulatory Interaction Network (9)
9 records.
Protein Complex Composition (49)
49 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| ATG101ATG13BLOC1S4FAM221BIER3IP1MGAT4APMELRB1CC1TMEM167AULK1WASHC2AWASHC3WASHC4WASHC5 | A6H8Z2O75143O75385P40967Q12768Q2M389Q641Q2Q8TBQ9Q8TDY2Q9BSB4Q9NUP1Q9UM21Q9Y3C0Q9Y5U9 | 0:0:0:0:0:0:0:0:0:0:0:0:0:0 | hu.MAP2 | |||
| WASLWIPF3 | A6NGB9O00401 | 0:0 | KEGG-MEDICUS | |||
| MEA1WASLWIPF1WIPF2WIPF3 | A6NGB9O00401O43516Q16626Q8TF74 | 0:0:0:0:0 | hu.MAP2 | |||
| WASLWIPF1WIPF2WIPF3 | A6NGB9O00401O43516Q8TF74 | 0:0:0:0 | hu.MAP2 | |||
| WASHC1WASHC2AWASHC2AWASHC2CWASHC3WASHC4WASHC5 | A8K0Z3Q12768Q2M389Q5SNT6Q641Q2Q9Y3C0Q9Y4E1 | 0:0:0:0:0:0:0 | Havugimana2012 | Havugimana2012:C_546 | ||
| WASLWIPF1 | O00401O43516 | 0:0 | KEGG-MEDICUS | |||
| NCK2WASF3WASL | O00401O43639Q9UPY6 | 0:0:0 | hu.MAP | |||
| WASLWIPF2 | O00401Q8TF74 | 0:0 | KEGG-MEDICUS | |||
| BLOC1S2BLOC1S6CCDC22DTNBP1NUP54NUP62WASHC3 | O60826P37198Q6QNY1Q7Z3B4Q96EV8Q9UL45Q9Y3C0 | 1:1:1:1:1:1:1 | NetworkBlastCompleat | Compleat:HC6471 | ||
| ABI2BLOC1S2BLOC1S6CCDC22DTNBP1NUP62WASHC3 | O60826P37198Q6QNY1Q96EV8Q9NYB9Q9UL45Q9Y3C0 | 1:1:1:1:1:1:1 | NetworkBlastCompleat | Compleat:HC7531 |
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Protein Organic Solvent Precipitation | Mass spectrometry | 1 | 32384937 |
Sequence, Structure & Domains12
Sequences
Length
502
Mass
52,913
Sequence
MSGGPMGGRPGGRGAPAVQQNIPSTLLQDHENQRLFEMLGRKCLTLATAVVQLYLALPPGAEHWTKEHCGAVCFVKDNPQKSYFIRLYGLQAGRLLWEQELYSQLVYSTPTPFFHTFAGDDCQAGLNFADEDEAQAFRALVQEKIQKRNQRQSGDRRQLPPPPTPANEERRGGLPPLPLHPGGDQGGPPVGPLSLGLATVDIQNPDITSSRYRGLPAPGPSPADKKRSGKKKISKADIGAPSGFKHVSHVGWDPQNGFDVNNLDPDLRSLFSRAGISEAQLTDAETSKLIYDFIEDQGGLEAVRQEMRRQEPLPPPPPPSRGGNQLPRPPIVGGNKGRSGPLPPVPLGIAPPPPTPRGPPPPGRGGPPPPPPPATGRSGPLPPPPPGAGGPPMPPPPPPPPPPPSSGNGPAPPPLPPALVPAGGLAPGGGRGALLDQIRQGIQLNKTPGAPESSALQPPPQSSEGLVGALMHVMQKRSRAIHSSDEGEDQAGDEDEDDEWDD
3D Structural Models
Turn
235..237; 254..256; 260..262; 272..275
Helix
265..271; 278..281; 284..296; 299..309; 432..440
Beta Strand
245..250
3D Structure
NMR spectroscopy (4); X-ray crystallography (2)
Domain & Motif Annotations
Compositional Bias
201..211; Polar residues; 341..419; Pro residues; 486..502; Acidic residues
Repeat
337..346; GRSGPLPPXP motif 1; 376..385; GRSGPLPPXP motif 2
Domain (CC)
The WH1 (Wasp homology 1) domain may bind a Pro-rich ligand.; DOMAIN: The CRIB (Cdc42/Rac-interactive-binding) region binds to the C-terminal WH2 domain in the autoinhibited state of the protein. Binding of Rho-type GTPases to the CRIB induces a conformation change and leads to activation.
Domain (FT)
39..148; WH1; 238..251; CRIB; 430..447; WH2
Region
146..240; Disordered; 307..502; Disordered
Clinical Relevance9
Disease Involvement (2)
Cancer-related genesDisease variant
Related Diseases
Biomarker
Phase 3
Drug Targets
Clinical trial target
Drugs
Interaction Protein (7)
ENSG00000010810ENSG00000070831ENSG00000071051ENSG00000115935ENSG00000130340ENSG00000140368ENSG00000158092
Interaction Count
7
Interaction Dataset
intact_biogrid
Supporting Publications15
| PMID | Title | Abstract |
|---|---|---|
| 38576002 | Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation. | No abstract available |
| 40091455 | Potential Role of Menstrual Fluid-Derived Small Extracellular Vesicle Proteins in Endometriosis Pathogenesiss. | No abstract available |
| 40098346 | Toward Identification of Markers for Brain-Derived Extracellular Vesicles in Cerebrospinal Fluid: A Large-Scale, Unbiased Analysis Using Proximity Extension Assays. | No abstract available |
| 40545963 | Extracellular Vesicle Proteome Analysis Improves Diagnosis of Recurrence in Triple-Negative Breast Cancer. | No abstract available |
| 40945317 | Comparing the proteome profiling of plasma-derived extracellular vesicles in individuals with schizophrenia and healthy controls: a pilot study. | No abstract available |
Page 2 of 2Previous